ContributorsPart I: The Basis of Addictive DisordersChapter 1. Neurobiology of AddictionChapter 2. Genetics of AddictionChapter 3. Epidemiology of AddictionChapter 4. Cross-Cultural Aspects of AddictionPart II: The Nature of TreatmentChapter 5. Science in the Treatment of Substance AbuseChapter 6. Assessment of the PatientChapter 7. Screening and Brief InterventionChapter 8. Patient Placement CriteriaChapter 9. "Recovery" in Chronic Care Disease Management: "Disease Control" in Substance Use DisordersPart III: Specific Drugs of AbuseChapter 10. Neurobiology of Alcohol Use DisorderChapter 11. Treatment of Alcohol Intoxication and Alcohol WithdrawalChapter 12. Neurobiology of StimulantsChapter 13. Clinical Management: CocaineChapter 14. Clinical Management: MethamphetamineChapter 15. Hallucinogens and Club DrugsChapter 16. Tobacco Use DisorderChapter 17. Benzodiazepines and Other Sedatives and HypnoticsChapter 18. Treatment of Anabolic-Androgenic Steroid--Related DisordersChapter 19. Neurobiology of Opiates and OpioidsChapter 20. Opioid DetoxificationChapter 21. Methadone and Buprenorphine MaintenanceChapter 22. Opioid AntagonistsChapter 23. Neurobiology of MarijuanaChapter 24. Treatment of Cannabis Use DisorderPart IV: Treatment ModalitiesChapter 25. Psychodynamic PsychotherapyChapter 26. Cognitive-Behavioral TherapiesChapter 27. Motivational EnhancementChapter 28. Twelve-Step Facilitation: An Adaptation for Psychiatric Practitioners and PatientsChapter 29. Contingency ManagementChapter 30. Network TherapyChapter 31. Group TherapyChapter 32. Family TherapyPart V: Rehabilitation SettingsChapter 33. Inpatient TreatmentChapter 34. Therapeutic CommunitiesChapter 35. Community-Based TreatmentChapter 36. History of Alcoholics Anonymous and the Experiences of PatientsChapter 37. Psychological Mechanisms in Alcoholics AnonymousChapter 38. Outcomes Research on Twelve-Step ProgramsPart VI: Special PopulationsChapter 39. Women and AddictionChapter 40. Perinatal Substance Use DisordersChapter 41. Adolescent Substance Use Disorders: Epidemiology, Neurobiology, and ScreeningChapter 42. Adolescent Substance Use Disorders: Transition to Substance Abuse, Prevention, and TreatmentChapter 43. Psychiatric Consultation in Pain and AddictionChapter 44. Prevention of Prescription Drug AbuseChapter 45. HIV/AIDS and Hepatitis CChapter 46. Substance Use Disorders Among PhysiciansChapter 47. Substance Use Issues Among Gay, Lesbian, Bisexual, and Transgender PeopleChapter 48. MinoritiesPart VII: Special TopicsChapter 49. Testing to Identify Recent Drug UseChapter 50. Medical Education on AddictionChapter 51. Prevention of Substance AbuseChapter 52. Forensic Addiction PsychiatryChapter 53. Substance Abuse and Mental IllnessAppendix: DSM-5 Substance-Related and Addictive DisordersIndex
The Fifth Edition of The American Psychiatric Publishing Textbook of Substance Abuse Treatment has covered all and relevant topics in the field of Addiction. Pedro Ruiz, M.D., Professor & Executive Vice Chair, Department of Psychiatry & Behavioral Sciences, University of Miami Miller School of Medicine President, World Psychiatry Association Marc Galanter, M.D., Herbert D. Kleber, M.D. and Kathleen T. Brady, M.D., Ph.D. have produced the 5th Edition of The American Psychiatric Publishing Textbook of Substance Abuse Treatment. In this edition the authors have covered the most essential issues related to addiction. Pedro Ruiz, M.D., Professor & Executive Vice Chair, Department of Psychiatry & Behavioral Sciences, University of Miami Miller School of Medicine President, World Psychiatry Association This 5th Edition of The American Psychiatric Publishing Textbook of Substance Abuse Treatment, edited by Dr. Marc Galanter, Dr. Herbert D. Kleber and Dr. Kathleen T. Brady, has covered and addressed all the relevant issues related to addictive disorders. Pedro Ruiz, M.D., Professor & Executive Vice Chair, Department of Psychiatry & Behavioral Sciences, University of Miami Miller School of Medicine President, World Psychiatry Association
Marc Galanter, M.D., is Professor of Psychiatry and Director of the Division of Alcoholism and Drug Abuse at NYU School of Medicine in New York, New York. Herbert D. Kleber, M.D., is Professor of Psychiatry and Director of the Division on Substance Abuse at Columbia University in New York, New York. Kathleen T. Brady, M.D., Ph.D., is Distinguished University Professor, Associate Provost of Clinical and Translational Research, and Director of the South Carolina Clinical and Translational Research Institute in Charleston, South Carolina.
The authors provide clearly structured examples of the essential elements of the assessmentprocess. Importantly, this text is fully updated to reflect the changes in the fifth edition of theDiagnostic and Statistical Manual of Mental Disorders (DSM-5). A comprehensive review of placement criteria highlights the important standard that no single method or level of care is appropriate for all individuals. Readers are shown how to develop an appropriate assessment process that applies to multiple treatment settings while also respecting the culture and individuality of each person presenting to treatment. -- John J. O'Neill, EdD, LCSW, LCDC, CAS, Vice President and Clinical Director, The Phoenix House, Austin, TX * Journal of Psychiatric Practice Vol. 23, No. 1 *